![Kendra Adams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kendra Adams
Financieel Directeur/CFO bij
C4 THERAPEUTICS, INC.
Vermogen: 210 958 $ op 30-06-2026
Profiel
Kendra R.
Adams is currently Treasurer, Chief Financial & Accounting Officer at C4 Therapeutics, Inc. since 2026.
Former positions include Director-Investor Relations at ARIAD Pharmaceuticals, Inc. and VP-External Communications & Investor Relations at Agios Pharmaceuticals, Inc. Education includes undergraduate studies at Hamilton College (New York).
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-04-2026 | 45.173 ( 0,04% ) | 210 958 $ | 30-06-2026 |
Actieve functies van Kendra Adams
| Bedrijven | Functie | Begin |
|---|---|---|
| C4 THERAPEUTICS, INC. | Financieel Directeur/CFO | 18-09-2023 |
Eerdere bekende functies van Kendra Adams
| Bedrijven | Functie | Einde |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Investor Relations Contact | - |
| ARIAD PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Opleiding van Kendra Adams
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
36
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Hamilton College (New York)
 Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
